Login
Home
Charts
Search
Watchlist
Products

Symphony Ltd

SYMPHONY·NSE
588.10-0.41%Wed, 23 Sept '26 13:15

Symphony Ltd

SYMPHONY
NSE
588.10
-0.41%
|Wed, 23 Sept '26 13:15
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
4,039Cr
Close
Close Price
588.10
Industry
Industry
Consumer Electronics
PE
Price To Earnings
PS
Price To Sales
3.63
Revenue
Revenue
1,112Cr
Rev Gr TTM
Revenue Growth TTM
-12.44%
PAT Gr TTM
PAT Growth TTM
-183.83%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
275247332393289242488251163233338378
Growth YoY
Revenue Growth YoY%
0.4-10.87.830.15.1-2.047.0-36.1-43.6-3.7-30.750.6
Expenses
ExpensesCr
234203275306212159381225139209288332
Operating Profit
Operating ProfitCr
4144578777831072624245046
OPM
OPM%
14.917.817.222.126.634.321.910.414.710.314.812.2
Other Income
Other IncomeCr
11159918-3911261312-19613
Interest Expense
Interest ExpenseCr
232002300453
Depreciation
DepreciationCr
766226523566
PBT
PBTCr
4350589493-11110503427-15750
Tax
TaxCr
8910623-23111986110
PAT
PATCr
3541488856-1079421919-21840
Growth YoY
PAT Growth YoY%
9.45.1200.0266.760.0-124.464.6-52.3-66.1290.0-375.9-4.8
NPM
NPM%
12.716.614.522.419.4-4.116.216.711.78.2-64.510.6
EPS
EPS
5.15.97.012.88.1-1.411.46.12.82.7-31.95.8
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
275247332393289242488251163233338378
Growth YoY
Revenue Growth YoY%
0.4-10.87.830.15.1-2.047.0-36.1-43.6-3.7-30.750.6
Expenses
ExpensesCr
234203275306212159381225139209288332
Operating Profit
Operating ProfitCr
4144578777831072624245046
OPM
OPM%
14.917.817.222.126.634.321.910.414.710.314.812.2
Other Income
Other IncomeCr
11159918-3911261312-19613
Interest Expense
Interest ExpenseCr
232002300453
Depreciation
DepreciationCr
766226523566
PBT
PBTCr
4350589493-11110503427-15750
Tax
TaxCr
8910623-23111986110
PAT
PATCr
3541488856-1079421919-21840
Growth YoY
PAT Growth YoY%
9.45.1200.0266.760.0-124.464.6-52.3-66.1290.0-375.9-4.8
NPM
NPM%
12.716.614.522.419.4-4.116.216.711.78.2-64.510.6
EPS
EPS
5.15.97.012.88.1-1.411.46.12.82.7-31.95.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4467687988441,1039001,0391,1881,1561,5761,1301,112
Growth
Revenue Growth%
72.43.95.730.7-18.415.514.3-2.636.3-28.3-12.4
Expenses
ExpensesCr
3105705797128917618781,0499871,2651,007968
Operating Profit
Operating ProfitCr
136198219132212139161138169311124144
OPM
OPM%
30.525.727.515.719.215.415.511.714.619.710.912.9
Other Income
Other IncomeCr
3343541551244050481-147-158
Interest Expense
Interest ExpenseCr
0027111191010101612
Depreciation
DepreciationCr
477102121242626222020
PBT
PBTCr
165234265130230131168152181280-59-46
Tax
TaxCr
466872394924473633678288
PAT
PATCr
11816619392182107121116148213-141-140
Growth
PAT Growth%
39.916.3-52.598.5-40.912.6-4.127.843.5-166.4-183.8
NPM
NPM%
26.621.624.110.816.511.911.69.812.813.5-12.5-12.6
EPS
EPS
16.923.827.513.126.015.317.216.721.431.2-20.5-20.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4467687988441,1039001,0391,1881,1561,5761,1301,112
Growth
Revenue Growth%
72.43.95.730.7-18.415.514.3-2.636.3-28.3-12.4
Expenses
ExpensesCr
3105705797128917618781,0499871,2651,007968
Operating Profit
Operating ProfitCr
136198219132212139161138169311124144
OPM
OPM%
30.525.727.515.719.215.415.511.714.619.710.912.9
Other Income
Other IncomeCr
3343541551244050481-147-158
Interest Expense
Interest ExpenseCr
0027111191010101612
Depreciation
DepreciationCr
477102121242626222020
PBT
PBTCr
165234265130230131168152181280-59-46
Tax
TaxCr
466872394924473633678288
PAT
PATCr
11816619392182107121116148213-141-140
Growth
PAT Growth%
39.916.3-52.598.5-40.912.6-4.127.843.5-166.4-183.8
NPM
NPM%
26.621.624.110.816.511.911.69.812.813.5-12.5-12.6
EPS
EPS
16.923.827.513.126.015.317.216.721.431.2-20.5-20.6

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
714141414141414141414
Reserves
ReservesCr
312445598652625745825867735747531
Current Liabilities
Current LiabilitiesCr
95133134265305274363400384544454
Non Current Liabilities
Non Current LiabilitiesCr
9711136116182159123852930
Total Liabilities
Total LiabilitiesCr
4225997571,0711,0641,2201,3671,4031,2181,3341,030
Current Assets
Current AssetsCr
177417497614626692835722618675691
Non Current Assets
Non Current AssetsCr
245182260457438527532682599659338
Total Assets
Total AssetsCr
4225997571,0711,0641,2201,3671,4031,2181,3341,030
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
714141414141414141414
Reserves
ReservesCr
312445598652625745825867735747531
Current Liabilities
Current LiabilitiesCr
95133134265305274363400384544454
Non Current Liabilities
Non Current LiabilitiesCr
9711136116182159123852930
Total Liabilities
Total LiabilitiesCr
4225997571,0711,0641,2201,3671,4031,2181,3341,030
Current Assets
Current AssetsCr
177417497614626692835722618675691
Non Current Assets
Non Current AssetsCr
245182260457438527532682599659338
Total Assets
Total AssetsCr
4225997571,0711,0641,2201,3671,4031,2181,3341,030

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
89951071401578957125162259-81
Investing Cash Flow
Investing Cash FlowCr
70-65-102-25078-536-11193-41190
Financing Cash Flow
Financing Cash FlowCr
-145-5-29118-241-21-34-124-367-224-95
Net Cash Flow
Net Cash FlowCr
1325-257-61429-10-12-614
Free Cash Flow
Free Cash FlowCr
84881081311407348114156237-96
CFO To PAT
CFO To PAT%
74.857.355.5152.486.382.647.0107.9109.1121.857.5
CFO To EBITDA
CFO To EBITDA%
65.148.048.7105.774.263.835.490.495.683.3-65.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
89951071401578957125162259-81
Investing Cash Flow
Investing Cash FlowCr
70-65-102-25078-536-11193-41190
Financing Cash Flow
Financing Cash FlowCr
-145-5-29118-241-21-34-124-367-224-95
Net Cash Flow
Net Cash FlowCr
1325-257-61429-10-12-614
Free Cash Flow
Free Cash FlowCr
84881081311407348114156237-96
CFO To PAT
CFO To PAT%
74.857.355.5152.486.382.647.0107.9109.1121.857.5
CFO To EBITDA
CFO To EBITDA%
65.148.048.7105.774.263.835.490.495.683.3-65.6

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
8,31410,66312,5119,6825,5348,8427,6767,1035,8517,6884,7194,039
Price To Earnings
Price To Earnings
82.764.165.0104.930.582.363.861.039.536.2
Price To Sales
Price To Sales
18.713.915.711.55.08.87.15.84.94.74.03.6
Price To Book
Price To Book
26.122.920.414.58.711.69.18.17.810.18.77.4
EV To EBITDA
EV To EBITDA
60.853.857.174.327.064.948.952.635.425.139.129.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
53.151.250.944.045.242.843.742.446.548.446.246.2
OPM
OPM%
30.525.727.515.719.215.415.511.714.619.710.912.9
NPM
NPM%
26.621.624.110.816.511.911.69.812.813.5-12.5-12.6
ROCE
ROCE%
51.848.941.816.128.414.516.114.620.832.1-6.0-6.0
ROE
ROE%
37.136.131.513.828.414.114.413.219.827.9-25.9-25.9
ROA
ROA%
28.027.725.48.617.18.88.88.312.215.9-13.7-13.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
8,31410,66312,5119,6825,5348,8427,6767,1035,8517,6884,7194,039
Price To Earnings
Price To Earnings
82.764.165.0104.930.582.363.861.039.536.2
Price To Sales
Price To Sales
18.713.915.711.55.08.87.15.84.94.74.03.6
Price To Book
Price To Book
26.122.920.414.58.711.69.18.17.810.18.77.4
EV To EBITDA
EV To EBITDA
60.853.857.174.327.064.948.952.635.425.139.129.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
53.151.250.944.045.242.843.742.446.548.446.246.2
OPM
OPM%
30.525.727.515.719.215.415.511.714.619.710.912.9
NPM
NPM%
26.621.624.110.816.511.911.69.812.813.5-12.5-12.6
ROCE
ROCE%
51.848.941.816.128.414.516.114.620.832.1-6.0-6.0
ROE
ROE%
37.136.131.513.828.414.114.413.219.827.9-25.9-25.9
ROA
ROA%
28.027.725.48.617.18.88.88.312.215.9-13.7-13.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Symphony Ltd is the world’s largest maker of evaporative air coolers by volume - a company that turned a humble appliance into a branded consumer product and then exported that playbook across sixty countries. Founded in 1988 in Ahmedabad by Achal Bakeri with the mission of delivering “universal cooling” that anyone could afford, it has sold more than twenty-five million coolers cumulatively, roughly four times its nearest global competitor. The recurring approach that explains everything else is an asset-light, brand-heavy model: Symphony designs the products, owns the intellectual property, and spends aggressively to make “Symphony” synonymous with the category, while outsourcing nearly all manufacturing to partner factories - so its capital is deployed in marketing and distribution, not in plant and machinery. # Business segments Three engines at different stages - a dominant Indian air-cooler franchise, a portfolio of counter-seasonal and adjacent products that smooth out the summer dependence, and an international network of subsidiaries being actively restructured - each built on the brand and distribution muscle of the one before. ## 1. Indian air coolers: the category-defining cash engine **Symphony owns roughly half the organised Indian air-cooler market, commands a price premium over every competitor, and has made its brand a generic noun - consumers walk into shops asking for a “Symphony,” not an air cooler.** - **The brand is the moat** - Symphony is the largest spender on brand-building in its sector, investing about 7.5% of standalone revenue annually, and generates roughly thirteen rupees of revenue for every rupee spent. Its share of voice across print, electronic and digital media has been over 50%, and its Net Promoter Score of 81 sits well above the industry standard. - **Priced above the rest** - the company commands a 10-15% premium over national brands and 30-40% over local ones, yet its market share in modern trade is higher than in general trade, with its general trade share estimated to be larger than the rest of the organised competition combined. - **A product for every pocket** - the portfolio spans personal coolers with six-litre tanks to desert coolers with 115-litre tanks, organised into sharply defined tiers: a weather-resistant “AirForce” series to convert metal-cooler buyers in rural markets, a “Maxwind” series for the value-conscious middle class, an ultra-quiet “Silenzo” line for upper-middle-class homes, and the premium “Arctic Circle” range. About 60% of revenue in FY24 came from models launched in the preceding five years, so the catalogue stays fresh. - **Large-space cooling is the quiet institutional franchise** - rebranded as Large Space Venti-Cooling (LSV), these units can moderate interior temperatures by nearly 10°C across 2,500 square feet at roughly one-tenth the electricity cost of air-conditioning. Symphony is the only organised player with fully indigenised manufacturing of LSV units, and clients include Delhivery, Big Basket, Welspun, and the Adyar Ananda Bhavan restaurant chain across 145-plus outlets. - **Distribution that reaches 18,000-plus pin codes** - a multi-channel network of 25,000-plus retail touchpoints, seventy-plus depots, and a direct-to-consumer website that now matches the margin of conventional trade, all supported by over a thousand service partners and four thousand trained engineers. ## 2. Beyond-India summer products: de-risking the calendar **A deliberately built portfolio of tower fans, kitchen fans, personal coolers, storage water heaters and exports that together contributed 49% of consolidated revenue in FY26, turning a seasonal business into a year-round one.** - **Fans and personal coolers for the metro home** - tower fans and personal cooling devices like the “Duet” (a fan-cooler hybrid with a detachable pedestal) are sold only in a focused set of large cities through select channels, so they do not cannibalise the core cooler trade. - **Water heaters fill the winter gap** - launched in FY25 with nine SKUs, the storage water-heater range uses “Puropod” technology to soften hard water and was introduced first through modern trade in a couple of states, with a plan to scale nationally via e-commerce. - **Exports are the long-term growth lever** - direct exports from India grew 83% in FY25, with focus markets in the USA, Brazil, Europe and the Middle East, and the company holds international certifications (CE, SASO, NOM, ETL) that open doors in regulated markets. Exports contribute about 10% of total turnover. ## 3. International subsidiaries: a global network under repair **A set of wholly-owned subsidiaries across Mexico, China, Australia, the USA and Brazil that were acquired to share research, market access and component sourcing - now being radically simplified after the Australian acquisition destroyed value.** - **Mexico is the turnaround that worked** - acquired in 2009 for under a million dollars, IMPCO is the only air-cooler brand in Mexico investing in marketing and new products; it registered its highest-ever revenue and profit in FY24 and grew 22% in FY25, though the Board is now exploring its sale. - **China is the research engine finally paying its way** - GSK China holds fifty-nine intellectual property rights and a state-of-the-art laboratory; it turned its first annual profit in fourteen years in FY25 while more than doubling revenue, and has nearly repaid its entire loan to the Indian parent. - **Australia was the capital-destruction episode** - acquired in 2018, Climate Technologies was hit by the world’s longest COVID lockdowns and then by regulation that forced the exit of its core gas-ducting products; despite cutting costs by more than half and shifting to an outsourced model, it lost sixty crore rupees over the last two years. In May 2026 the Board impaired the entire ₹348-crore equity investment and declared no further capital would be allocated. - **The US and Brazil are the bright spots being ring-fenced** - Bonaire USA sells to Home Depot, Lowe’s and Amazon, and its profitability held intact through the tariff turmoil of FY26; in June 2026 Symphony bought it out of the Australian structure to make it a direct subsidiary, alongside acquiring the Bonaire brand IP. Brazil nearly quadrupled revenue in its first full year and grew over 50% in FY25. # Group structure and partners **Symphony Limited sits at the centre of a web of wholly-owned subsidiaries that it is actively pruning - selling or impairing the underperformers while pulling the valuable American and Chinese assets closer to the parent.** - The parent company is governed by a nine-member Board and has a capital-allocation policy that commits to distributing at least 60% of consolidated profit after tax; over the last five years the payout ratio averaged 99%. - The Mexican subsidiary (IMPCO) and the Australian holding company (Symphony AU Pty Limited) were both classified as “Assets held for Sale” in April 2025, with investment bankers appointed to explore divestment. - In mid-2026, Symphony used its own treasury to acquire the Bonaire USA entity and the Bonaire brand IP from the Australian subsidiary for a combined \~₹52 crore, severing the valuable US business from the loss-making Australian operations. - GSK China incorporated a step-down trading subsidiary, Dongguan GSK Appliances, in August 2024 to sell third-party-manufactured products - including air conditioners and heaters - to international customers, broadening its revenue base beyond its own factory output. - Global retail partners include The Home Depot (over 2,200 outlets in the USA), Lowe’s, and Amazon in North America, and JD.com in China, where GSK became a preferred supplier for warehouse cooling.

Documents — Symphony Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/5ro6y0jwj1s2fr217ii28f63.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/3bo5ix7wzwbl0f7t9vvo49a1.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/s2pz6nh2yx3rwu31fu5vngvk.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/6l320adb1v5kagw9e6ffhu27.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/zrb33r8cwgnr9ovbzkckruee.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/j3dr07eb8ofsikwvhhfq57um.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/auaxdg0ar46vl2lr6ym7fa03.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/v53jjtdk30v9ic1xuibx08dt.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/jo9hzsuxo1o9oycq6btvb2mg.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/4lr8w2b0zxfrskcnfkra3kk6.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/np2relx0f3c4lq7g1yxl52ih.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/bi2jzrp0ono7pcniu8mcigbt.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/ly35rjtbeuqaiy9y4010oele.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/r23pnn5atdbucnkyt0yi41to.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/yyeqy1hjhhdb5nvjlc24kj80.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/eheo1wcicci6bys2o4bd2fgn.pdf
  • Q1 FY2022 Investor Presentation (Jun 2021, PDF): https://www.stockscans.in/document/5cydxnz4r76mmhfb92s3eylq.pdf
  • Q4 FY2021 Investor Presentation (Mar 2021, PDF): https://www.stockscans.in/document/muenbkqhhyno8fx915cgp5pl.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/cxg18pkb6e42s4p9eet7h5p0.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/cuielwf9yd4mdai334cq14k3.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/61s734nw94sx48xo9qylms72.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/gwhx86gi8tu6k1vvr0fpbxdo.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/oedd3ozmtigam4q38p2eim85.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/oe2qev8wy1kwu5j1x3r27e7x.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/d4jtyipkz7e4tr2u0ggay4gs.pdf

Concall Transcript Summaries — Symphony Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3ASYMPHONY/transcript-notes/202606/5ro6y0jwj1s2fr217ii28f63.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ASYMPHONY/transcript-notes/202603/3bo5ix7wzwbl0f7t9vvo49a1.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3ASYMPHONY/transcript-notes/202512/s2pz6nh2yx3rwu31fu5vngvk.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ASYMPHONY/transcript-notes/202509/6l320adb1v5kagw9e6ffhu27.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3ASYMPHONY/transcript-notes/202506/zrb33r8cwgnr9ovbzkckruee.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3ASYMPHONY/transcript-notes/202503/j3dr07eb8ofsikwvhhfq57um.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3ASYMPHONY/transcript-notes/202412/auaxdg0ar46vl2lr6ym7fa03.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3ASYMPHONY/transcript-notes/202409/v53jjtdk30v9ic1xuibx08dt.pdf